Information Provided By:
Fly News Breaks for January 25, 2017
Jan 25, 2017 | 07:05 EDT
Rodman & Renshaw analyst Raghuram Selvaraju downgraded GenVec (GNVC) to Neutral citing the takeover by Intrexon (XON). The analyst views the offer as "decent" and lowered his price target for GenVac shares to $7 from $15.
News For GNVC;XON From the Last 2 Days
There are no results for your query GNVC;XON